ALPHARETTA, Ga., May 23, 2016 /PRNewswire/ -- EndoChoice
Holdings, Inc. (NYSE: GI) announced it received 510(k)
clearance for its new Orca™ sterile, single-use air/water and
suction valves for Olympus® 160, 180 and 190 Series
flexible endoscopes. Recently published clinical guidelines
from Association for the Advancement of Medical Instrumentation
(AAMI) and the Society of Gastroenterology Nurses and Associates
(SGNA), state that reusable endoscopic accessories (e.g., air/water
and suction valves) should be reprocessed together and stored with
a specific endoscope as a unique set to ensure traceability.
By eliminating the need to clean and disinfect reusable valves, the
single use Orca™ valves allow clinicians to adhere to these new
guidelines while improving patient care and workflow
efficiency. The company will begin sales and distribution of
the new valves in the United
States, European Union, and other select markets.
EndoChoice will highlight the new sterile, single-use valves at
Digestive Disease Week® (DDW®) in San
Diego, California (Booth #4317), and at the SGNA™
43rd Annual Course in Seattle, Washington. EndoChoice will
display at these meetings May 22 to
24.
Commenting on the announcement, Mark
Gilreath, Founder and CEO of EndoChoice said, "EndoChoice
has been dedicated to improving the standard of care for infection
control since 2010, when it launched the Compliance
EndoKit®, the first GI procedural kit designed to help
clinicians standardize to good infection control practices.
The Orca™ sterile single use air/water and suction valves are an
excellent addition to the Compliance EndoKit®, thus
continuing to improve the standard of care in GI."
About EndoChoice
Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech
company focused on the manufacturing and commercialization of
platform technologies including endoscopic imaging systems, devices
and infection control products and pathology services for
specialists treating a wide range of gastrointestinal conditions,
including colon cancer. EndoChoice leverages its direct sales
organization to serve more than 2,500 customers in the United
States and works with distribution partners in 30 countries.
The Company was founded in 2008 and has rapidly developed a broad
and innovative product portfolio, which includes the Full Spectrum
Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full
Spectrum Endoscopy are registered trademarks of EndoChoice,
Inc.
For more information, press only:
Company Contact:
Ryan Moskowitz
Senior Director, Marketing Communications
EndoChoice
678-708-4403
ryan.moskowitz@endochoice.com
Investor Contacts:
Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
nlaudico@theruthgroup.com
zkubow@theruthgroup.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/endochoice-announces-fda-clearance-of-its-orca-sterile-single-use-airwater-and-suction-valves-300273174.html
SOURCE EndoChoice